Effect of SHR8058 on Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction
Clinical trial NCT05515471 · COMPLETED
Trial details
- NCT number
- NCT05515471
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-04
- Primary completion
- 2021-09-07
- Enrollment
- 312
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.